Status:
AVAILABLE
Expanded Access to Fosigotifator
Lead Sponsor:
AbbVie
Conditions:
Vanishing White Matter
Cree Leukoencephalopathy
Eligibility:
All Genders
Brief Summary
This is an expanded access program (EAP) for eligible participants. This program is designed to provide access to Fosigotifator prior to approval by the local regulatory agency. Availability will depe...
Eligibility Criteria
Inclusion
Exclusion
Key Trial Info
Start Date :
Trial Type :
EXPANDED_ACCESS
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT06594016
Last Update
September 16 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.